Genetic Signatures Ltd (GSS) - Net Assets

Latest as of June 2025: AU$50.09 Million AUD ≈ $35.44 Million USD

Based on the latest financial reports, Genetic Signatures Ltd (GSS) has net assets worth AU$50.09 Million AUD (≈ $35.44 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$54.63 Million ≈ $38.65 Million USD) and total liabilities (AU$4.54 Million ≈ $3.21 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Genetic Signatures Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$50.09 Million
% of Total Assets	91.69%
Annual Growth Rate	N/A
5-Year Change	1.53%
10-Year Change	970.43%
Growth Volatility	121.61

Genetic Signatures Ltd - Net Assets Trend (2013–2025)

This chart illustrates how Genetic Signatures Ltd's net assets have evolved over time, based on quarterly financial data. Also explore GSS total asset value for the complete picture of this company's asset base.

Annual Net Assets for Genetic Signatures Ltd (2013–2025)

The table below shows the annual net assets of Genetic Signatures Ltd from 2013 to 2025. For live valuation and market cap data, see GSS market cap.

Year	Net Assets	Change
2025-06-30	AU$50.09 Million ≈ $35.44 Million	-18.02%
2024-06-30	AU$61.10 Million ≈ $43.23 Million	+42.38%
2023-06-30	AU$42.91 Million ≈ $30.36 Million	-21.69%
2022-06-30	AU$54.80 Million ≈ $38.78 Million	+11.07%
2021-06-30	AU$49.34 Million ≈ $34.91 Million	+7.43%
2020-06-30	AU$45.93 Million ≈ $32.50 Million	+334.56%
2019-06-30	AU$10.57 Million ≈ $7.48 Million	-21.12%
2018-06-30	AU$13.40 Million ≈ $9.48 Million	-18.72%
2017-06-30	AU$16.49 Million ≈ $11.66 Million	+252.27%
2016-06-30	AU$4.68 Million ≈ $3.31 Million	-33.69%
2015-06-30	AU$7.06 Million ≈ $4.99 Million	-56.38%
2014-06-30	AU$16.18 Million ≈ $11.45 Million	+587.83%
2013-06-30	AU$-3.32 Million ≈ $-2.35 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Genetic Signatures Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 6476963900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	AU$127.64 Million	254.82%
Other Comprehensive Income	AU$9.56 Million	19.09%
Total Equity	AU$50.09 Million	100.00%

Genetic Signatures Ltd Competitors by Market Cap

The table below lists competitors of Genetic Signatures Ltd ranked by their market capitalization.

Company	Market Cap
Nvni Group Limited Ordinary Shares NASDAQ:NVNI	$14.15 Million
Harta Djaya Karya Tbk Pt JK:MEJA	$14.15 Million
NSX Ltd AU:NSX	$14.16 Million
oodash Group AB (publ) ST:OODA	$14.16 Million
Grupo Televisa SAB DRC BA:TV	$14.13 Million
Sequoia Econ Infrastructure LSE:SEQI	$14.12 Million
MSCM Holdings Bhd KLSE:0041	$14.11 Million
RECYCLICO BATTERY METALS F:ID4	$14.11 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Genetic Signatures Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 61,103,000 to 50,093,000, a change of -11,010,000 (-18.0%).
Net loss of 20,104,000 reduced equity.
Share repurchases of 554,000 reduced equity.
New share issuances of 8,769,000 increased equity.
Other comprehensive income increased equity by 879,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-20.10 Million	-40.13%
Share Repurchases	AU$554.00K	-1.11%
Share Issuances	AU$8.77 Million	+17.51%
Other Comprehensive Income	AU$879.00K	+1.75%
Total Change	AU$-	-18.02%

Book Value vs Market Value Analysis

This analysis compares Genetic Signatures Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.40x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-06-30	AU$-0.13	AU$0.09	x
2014-06-30	AU$0.23	AU$0.09	x
2015-06-30	AU$0.14	AU$0.09	x
2016-06-30	AU$0.06	AU$0.09	x
2017-06-30	AU$0.17	AU$0.09	x
2018-06-30	AU$0.13	AU$0.09	x
2019-06-30	AU$0.10	AU$0.09	x
2020-06-30	AU$0.35	AU$0.09	x
2021-06-30	AU$0.33	AU$0.09	x
2022-06-30	AU$0.37	AU$0.09	x
2023-06-30	AU$0.29	AU$0.09	x
2024-06-30	AU$0.37	AU$0.09	x
2025-06-30	AU$0.22	AU$0.09	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Genetic Signatures Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -40.13%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -126.44%
• Asset Turnover: 0.29x
• Equity Multiplier: 1.09x
Recent ROE (-40.13%) is below the historical average (-21.85%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	0.00%	-783.88%	0.28x	0.00x	AU$-1.68 Million
2014	-10.68%	-133.73%	0.08x	1.02x	AU$-3.35 Million
2015	-37.68%	-254.88%	0.13x	1.11x	AU$-3.36 Million
2016	-64.67%	-92.68%	0.55x	1.27x	AU$-3.49 Million
2017	-16.20%	-65.75%	0.23x	1.07x	AU$-4.32 Million
2018	-24.28%	-65.16%	0.34x	1.09x	AU$-4.59 Million
2019	-33.04%	-49.72%	0.58x	1.15x	AU$-4.55 Million
2020	-4.54%	-18.52%	0.23x	1.08x	AU$-6.68 Million
2021	3.56%	6.21%	0.52x	1.10x	AU$-3.18 Million
2022	5.59%	8.65%	0.59x	1.09x	AU$-2.42 Million
2023	-32.74%	-82.96%	0.35x	1.14x	AU$-18.34 Million
2024	-29.23%	-182.90%	0.15x	1.10x	AU$-23.97 Million
2025	-40.13%	-126.44%	0.29x	1.09x	AU$-25.11 Million

Industry Comparison

This section compares Genetic Signatures Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $287,385,052
Average return on equity (ROE) among peers: -37.53%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Genetic Signatures Ltd (GSS)	AU$50.09 Million	0.00%	0.09x	$14.14 Million
Australian Clinical Labs Ltd (ACL)	$14.12 Million	-170.17%	7.56x	$256.90 Million
Bcal Diagnostics Ltd (BDX)	$9.64 Million	-35.12%	0.10x	$21.65 Million
Cryosite Ltd (CTE)	$3.87 Million	-25.46%	0.05x	$39.72 Million
Genetic Technologies Ltd (GTG)	$20.83 Million	-26.20%	0.16x	$4.01 Million
Healius Ltd (HLS)	$2.50 Billion	3.13%	0.53x	$254.32 Million
Imagion Biosystems Ltd (IBX)	$13.31 Million	-45.28%	0.06x	$5.90 Million
Integral Diagnostics Ltd (IDX)	$2.54 Million	127.10%	0.00x	$585.79 Million
Inoviq Ltd (IIQ)	$2.83 Million	-115.42%	0.16x	$32.37 Million
Microba Life Sciences Ltd (MAP)	$14.94 Million	-50.37%	0.24x	$32.75 Million

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$14.14 Million

AU$19.99 Million AUD

Market Cap Rank

#26008 Global

#1223 in Australia

Share Price

AU$0.09

Change (1 day)

+7.32%

52-Week Range

AU$0.08 - AU$0.68

All Time High

AU$2.75